about
MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages.Vascular endothelium in atherosclerosis.Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis.Glycated LDL increase VCAM-1 expression and secretion in endothelial cells and promote monocyte adhesion through mechanisms involving endoplasmic reticulum stress.Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose.Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress.Endothelial cell response to hyperlipemia. Activation-dysfunction-injury, the protective role of simvastatin.Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL.Oxidized LDL-Exposed Human Macrophages Display Increased MMP-9 Expression and Secretion Mediated by Endoplasmic Reticulum Stress.Hyperlipidemia-induced hepatic and small intestine ER stress and decreased paraoxonase 1 expression and activity is associated with HDL dysfunction in Syrian hamsters.Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters.Apolipoprotein E polymorphism--a risk factor for metabolic syndromeModified low density lipoproteins decrease the activity and expression of lysosomal acid lipase in human endothelial and smooth muscle cellsHyperlipidemia Determines Dysfunctional HDL Production and Impedes Cholesterol Efflux in the Small Intestine: Alleviation by Ginger Extract
P50
Q35814698-4A563B64-031F-4AB6-9FFB-5874AE73DA1AQ36102976-4E01FDB5-872B-4DD8-86F4-4906DAB81EB3Q37271748-F6B24090-E9C2-45E8-9894-B5DC257F0A5BQ38010641-0C6A89BF-0ED2-4A7A-A9A3-ABA48860E128Q38769631-776C7F4E-E83B-4589-B9A0-27CFD6384C85Q39784547-089C3F1C-BFCC-491B-96BF-E6F9C187A098Q41940233-6AC80D8D-6906-4C84-9B07-BD9F5F48C8FEQ42528747-57D27DF7-2511-48BB-BC5E-049D2918C337Q44137767-B87641C8-70B4-42CF-92C0-3B569E0BBE82Q46527622-52A6AC21-293C-42CE-8AB4-1C556132EB81Q51741393-BBE5DD4D-31EF-406D-BE2C-7D4FBED9F5B7Q51751625-05BBDD42-7CB0-4DA9-A925-F905A51030CFQ81233537-B51B7319-5A24-4FFF-8A97-D109415E2787Q83887356-68F60B7D-EE5A-417F-BB56-0C1EA542DDE0Q91797779-7D070877-FA22-42F5-8F79-2C2F9624B939
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Camelia S Stancu
@nl
Camelia S Stancu
@sl
Camelia S. Stancu
@en
Camelia S. Stancu
@es
type
label
Camelia S Stancu
@nl
Camelia S Stancu
@sl
Camelia S. Stancu
@en
Camelia S. Stancu
@es
prefLabel
Camelia S Stancu
@nl
Camelia S Stancu
@sl
Camelia S. Stancu
@en
Camelia S. Stancu
@es
P106
P1153
7004593308
P21
P31
P496
0000-0002-2988-9961